guanfacine has been researched along with Adverse Drug Event in 7 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Excerpt | Relevance | Reference |
---|---|---|
" Trials of amphetamines, atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with a placebo arm and reporting data on headache as an adverse event, were included." | 2.82 | Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. ( Banaschewski, T; Bölte, S; Buitelaar, JK; Coghill, D; Cortese, S; Häge, A; Hohmann, S; Jonsson, U; Nobel Norrman, H; Pan, PY; Şahpazoğlu Çakmak, SS, 2022) |
"5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Matthews, EJ | 1 |
Kruhlak, NL | 1 |
Weaver, JL | 1 |
Benz, RD | 1 |
Contrera, JF | 1 |
Liu, Z | 1 |
Shi, Q | 1 |
Ding, D | 1 |
Kelly, R | 1 |
Fang, H | 1 |
Tong, W | 1 |
Morgan, RE | 1 |
van Staden, CJ | 1 |
Chen, Y | 1 |
Kalyanaraman, N | 1 |
Kalanzi, J | 1 |
Dunn, RT | 1 |
Afshari, CA | 1 |
Hamadeh, HK | 1 |
Pan, PY | 1 |
Jonsson, U | 1 |
Şahpazoğlu Çakmak, SS | 1 |
Häge, A | 1 |
Hohmann, S | 1 |
Nobel Norrman, H | 1 |
Buitelaar, JK | 1 |
Banaschewski, T | 1 |
Cortese, S | 1 |
Coghill, D | 1 |
Bölte, S | 1 |
Elliott, J | 1 |
Johnston, A | 1 |
Husereau, D | 1 |
Kelly, SE | 1 |
Eagles, C | 1 |
Charach, A | 1 |
Hsieh, SC | 1 |
Bai, Z | 1 |
Hossain, A | 1 |
Skidmore, B | 1 |
Tsakonas, E | 1 |
Chojecki, D | 1 |
Mamdani, M | 1 |
Wells, GA | 1 |
Hasan, SS | 1 |
Bal, N | 1 |
Baker, I | 1 |
Kow, CS | 1 |
Khan, MU | 1 |
Duong, S | 1 |
Chung, K | 1 |
Wigal, SB | 1 |
3 reviews available for guanfacine and Adverse Drug Event
Article | Year |
---|---|
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2022 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes | 2020 |
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nerv | 2012 |
4 other studies available for guanfacine and Adverse Drug Event
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Adverse Drug Reaction Reporting and Prescribing Trends of Drugs for Attention Deficit Hyperactivity Disorder in Primary Care England, 2010-2019.
Topics: Attention Deficit Disorder with Hyperactivity; Databases, Factual; Drug-Related Side Effects and Adv | 2022 |